Immunotherapy to Prevent Multiple Myeloma Relapse

Learning Objectives:

• Review the clinical challenge of relapse in multiple myeloma.
• Describe the promise and limitations of current cellular immunotherapy strategies for multiple myeloma.
• Describe the rationale and initial results with co-targeting BCMA and CD19 in multiple myeloma.
• Articulate the rationale for immunotherapies to induce anti-Sox2 immunity in multiple myeloma.

Alfred L. Garfall, M.D.

Assistant Professor of Medicine

Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania

LOCATION  Virtually, via Zoom

ATTENDANCE / CREDPIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

ABOUT Cancer Center Grand Rounds are held weekly on Thursdays for faculty and junior faculty, investigators and junior investigators, scholars, graduate students, medical students, research fellows, administration and allied health staff.

ARCHIVED PRESENTATIONS Located in Arizona Cancer Center Grand Rounds Video Library

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.